calcium acetate has been researched along with Kidney Failure, Chronic in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 31 (60.78) | 29.6817 |
| 2010's | 19 (37.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlain, S; Mole, DR; Protheroe, A; Purshouse, K; Soares, M; Tuthill, M | 1 |
| Huynh, T; Nguyen, T; Pham, T | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Büschges-Seraphin, B; Covic, A; de Francisco, AL; Ghenu, A; Kroczak, M; Marzell, B; Passlick-Deetjen, J; Ponce, P | 1 |
| St Peter, WL; Weinhandl, ED; Yusuf, AA | 1 |
| Alfieri, T; Anum, EA; Braunhofer, P; Newsome, B; Ramakrishnan, K; Wang, S | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE | 1 |
| Copland, M; Komenda, P; McCullough, PA; Morfin, JA; Weinhandl, ED | 1 |
| Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
| De Vos, JY; Elseviers, M | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Khan, DA; Khan, FA; Saif, I | 1 |
| Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 2 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Noto, L | 1 |
| Kim, TH; Yang, SY | 1 |
| Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Chandraker, A; Grafals, M; Rennke, HG; Riella, LV | 1 |
| Brenchley, PE; Hutchison, AJ; Smith, CP | 1 |
| Bledsoe, AL; Kaplan, MR; McGowan, J; Stashenko, CL | 1 |
| Cleveland, M | 1 |
| Cerezo, S; Hervás, JG; Prados, D | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Bleyer, AJ | 1 |
| Nolan, CR; Qunibi, WY | 3 |
| Paret, CL | 1 |
| Bommer, J; Chertow, GM; Raggi, P | 1 |
| Cobanoglu, B; Coskun, B; Karincaoglu, Y; Ozturk, P; Saral, Y | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Little, G; Otoo, A | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Tonelli, M; Winkelmayer, WC | 1 |
| Böttger, WM; Gelens, MA; Kaufmann, BG; Klaassen, HA; van den Bergh, JP; Verstappen, VM | 1 |
| Llach, F; Yudd, M | 1 |
| Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
| Dennis, VW; Fatica, RA | 1 |
| Malluche, HH; Mawad, H | 1 |
13 review(s) available for calcium acetate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Topics: Acetates; Bone Diseases; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis; Sevelamer | 2016 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Pharmacology, efficacy and safety of oral phosphate binders.
Topics: Acetates; Animals; Calcium Compounds; Chelating Agents; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lanthanum; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Topics: Acetates; Calcium; Calcium Compounds; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.
Topics: Acetates; Calcium Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders | 2002 |
15 trial(s) available for calcium acetate and Kidney Failure, Chronic
| Article | Year |
|---|---|
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium Compounds; Chelating Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Function Tests; Magnesium; Male; Middle Aged; Parathyroid Hormone; Polyamines; Prognosis; Renal Dialysis; Risk Factors; Sevelamer; Young Adult | 2013 |
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2015 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
A preference study: calcium acetate tablets versus gelcaps in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Female; Gels; Humans; Kidney Failure, Chronic; Male; Middle Aged; Patient Satisfaction; Phosphates; Renal Dialysis; Tablets; Treatment Refusal | 2002 |
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Compounds; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome | 2006 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Female; Hemodialysis Solutions; Hospitalization; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2008 |
Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium; Calcium Compounds; Chemistry, Pharmaceutical; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis; Tablets, Enteric-Coated | 1999 |
23 other study(ies) available for calcium acetate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
Topics: Acetates; Aged, 80 and over; Calcium Compounds; Carcinoma, Renal Cell; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Oxalates; Pancreatic Neoplasms; Pancrelipase; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis; Sulfonamides; Treatment Outcome | 2019 |
Phosphate binder choices used in ESRD patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Retrospective Studies; Sevelamer; Young Adult | 2016 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Female; Humans; Hyperphosphatemia; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Medicare Part D; Polyamines; Renal Dialysis; Sevelamer; Survival Rate; Treatment Outcome; United States | 2014 |
Reasons for phosphate binder discontinuation vary by binder type.
Topics: Acetates; Adult; Aged; Calcium Compounds; Female; Gastrointestinal Tract; Humans; Hypercalcemia; Hypophosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome; United States | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis | 2009 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient.
Topics: Acetates; Biopsy; Calcinosis; Calcium Compounds; Chelating Agents; Fiber Optic Technology; Gastroscopy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stomach Diseases; Vitamin D; Vitamins | 2010 |
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy.
Topics: Acetates; Administration, Oral; Aged; Biopsy; Calcium Compounds; Creatinine; Female; Humans; Hypophosphatemia; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Phosphates; Renal Insufficiency; Treatment Outcome | 2011 |
Calcium on trial: beyond a reasonable doubt?
Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis | 2003 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Calcium acetate-induced linear fixed drug eruption.
Topics: Acetates; Calcium Compounds; Diagnosis, Differential; Drug Eruptions; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Conflict, Psychological; Disease Management; Humans; Kidney Failure, Chronic; Phosphates; Treatment Outcome; United States | 2006 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Topics: Acetates; Calcium Compounds; Chelating Agents; Hemodialysis Solutions; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Research Design; Sevelamer | 2008 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |